{"id":"lcs16","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site reactions"},{"rate":"null","effect":"Musculoskeletal pain"},{"rate":"null","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting PCSK9, LCS16 increases the levels of low-density lipoprotein (LDL) receptors on the liver surface, leading to reduced levels of LDL cholesterol in the blood.","oneSentence":"LCS16 is a small molecule that inhibits the PCSK9 enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:18:24.094Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypercholesterolemia"}]},"trialDetails":[{"nctId":"NCT03074045","phase":"PHASE3","title":"LCS16 vs. COC User Satisfaction and Tolerability Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2017-03-13","conditions":"Contraception","enrollment":145},{"nctId":"NCT00528112","phase":"PHASE3","title":"Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Contraception","enrollment":2885},{"nctId":"NCT00185380","phase":"PHASE2","title":"Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-04","conditions":"Contraception","enrollment":742}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"LCS16","genericName":"LCS16","companyName":"Bayer","companyId":"bayer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"LCS16 is a small molecule that inhibits the PCSK9 enzyme. Used for Hypercholesterolemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}